Literature DB >> 3257596

Analyses of the cytotoxic T lymphocyte responses to glycoprotein and nucleoprotein components of lymphocytic choriomeningitis virus.

J L Whitton1, P J Southern, M B Oldstone.   

Abstract

The outcome of infection by lymphocytic choriomeningitis virus (LCMV) in the natural murine host is determined in large part by the cytotoxic T lymphocyte response (CTL) mounted by the host. In order to define the specificities of CTL induced by LCMV infection, we have cloned and expressed the full-length nucleoprotein (NP) gene and 75% of the glycoprotein (GP) gene of LCMV in vaccinia virus vectors and have used these recombinant viruses to sensitize syngeneic target cells to lysis by anti-LCMV CTL. We have studied the anti-LCMV CTL responses induced on three different mouse H2 (major histocompatibility complex) backgrounds. First, we find that the relative recognition of the two LCMV proteins differs markedly on different H2 haplotypes; both proteins are seen on the H2bb background, while only NP is recognized on two other haplotypes (H2dd and H2qq). Second, we show that on the H2bb background the anti-GP CTL response comprises a major component of the overall CTL response, in marked contrast to several other viruses, e.g., influenza virus, vesicular stomatitis virus, and respiratory syncytial virus where anti-GP responses, if present, comprise only a minor portion of the whole. Third, LCMV GP can be a major target antigen for CTL induced by a serotypically distinct strain of LCMV, again in contrast to the above virus systems in which CTL cross-reactivity among different serotypes is dependent largely on the recognition of "internal" proteins.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3257596     DOI: 10.1016/0042-6822(88)90471-0

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  69 in total

1.  Expression of adenoviral E3 transgenes in beta cells prevents autoimmune diabetes.

Authors:  M G von Herrath; S Efrat; M B Oldstone; M S Horwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  Diversity of T-cell receptors in virus-specific cytotoxic T lymphocytes recognizing three distinct viral epitopes restricted by a single major histocompatibility complex molecule.

Authors:  Y Yanagi; A Tishon; H Lewicki; B A Cubitt; M B Oldstone
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

3.  The Anatomy of a Career in Science.

Authors:  Michael B A Oldstone
Journal:  DNA Cell Biol       Date:  2016-02-02       Impact factor: 3.311

4.  Evaluation of non-reciprocal heterologous immunity between unrelated viruses.

Authors:  Jenny W Che; Liisa K Selin; Raymond M Welsh
Journal:  Virology       Date:  2015-03-31       Impact factor: 3.616

5.  Virus-induced diabetes in a transgenic model: role of cross-reacting viruses and quantitation of effector T cells needed to cause disease.

Authors:  N Sevilla; D Homann; M von Herrath; F Rodriguez; S Harkins; J L Whitton; M B Oldstone
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

6.  Virus-specific, CD8+ major histocompatibility complex class I-restricted cytotoxic T lymphocytes in lymphocytic choriomeningitis virus-infected beta2-microglobulin-deficient mice.

Authors:  D G Quinn; A J Zajac; C E Hioe; J A Frelinger
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

7.  Immunization with non-replicating E. coli minicells delivering both protein antigen and DNA protects mice from lethal challenge with lymphocytic choriomeningitis virus.

Authors:  Matthew J Giacalone; Juan C Zapata; Neil L Berkley; Roger A Sabbadini; Yen-Lin Chu; Maria S Salvato; Kathleen L McGuire
Journal:  Vaccine       Date:  2006-12-26       Impact factor: 3.641

8.  Mucosal immunization with Salmonella typhimurium expressing Lassa virus nucleocapsid protein cross-protects mice from lethal challenge with lymphocytic choriomeningitis virus.

Authors:  M Djavani; C Yin; I S Lukashevich; J Rodas; S K Rai; M S Salvato
Journal:  J Hum Virol       Date:  2001 Mar-Apr

9.  LCMV-mediated hepatitis in rhesus macaques: WE but not ARM strain activates hepatocytes and induces liver regeneration.

Authors:  I S Lukashevich; J D Rodas; I I Tikhonov; J C Zapata; Y Yang; M Djavani; M S Salvato
Journal:  Arch Virol       Date:  2004-08-30       Impact factor: 2.574

10.  Effect of immune priming on Borna disease.

Authors:  A J Lewis; J L Whitton; C G Hatalski; H Weissenböck; W I Lipkin
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.